Today we announced that we have received regulatory authorization from @anvisa_oficial in Brazil to initiate our global Phase 3 trial for INO-4800, our #DNAVaccine candidate for #COVID19 developed in partnership with Advaccine. Learn more: https://nitter.gq/t.co/9OG5fUzyQ1